Its unique modular nature enables the design of constructs with the specificity to distinct cancer antigens and the CD16A or other NK-cell receptors, leading to NK cell and macrophage recruitment, independently of the CD16A 158V/F polymorphism, and the activation of NK cell-mediated ADCC and macrophage-mediated ADCP [24]. The gene discussed is KLRD1; the disease is cancer.